|
US3906092A
(en)
|
1971-11-26 |
1975-09-16 |
Merck & Co Inc |
Stimulation of antibody response
|
|
GB2134869A
(en)
|
1983-02-15 |
1984-08-22 |
Squibb & Sons Inc |
Method of preparing liposomes and products produced thereby
|
|
US4610868A
(en)
|
1984-03-20 |
1986-09-09 |
The Liposome Company, Inc. |
Lipid matrix carriers for use in drug delivery systems
|
|
US5897873A
(en)
|
1984-04-12 |
1999-04-27 |
The Liposome Company, Inc. |
Affinity associated vaccine
|
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US4806352A
(en)
|
1986-04-15 |
1989-02-21 |
Ribi Immunochem Research Inc. |
Immunological lipid emulsion adjuvant
|
|
US4803070A
(en)
|
1986-04-15 |
1989-02-07 |
Ribi Immunochem Research Inc. |
Immunological emulsion adjuvants for polysaccharide vaccines
|
|
US4806350A
(en)
|
1986-04-18 |
1989-02-21 |
Norden Laboratories, Inc. |
Vaccine formulation
|
|
US5084269A
(en)
|
1986-11-06 |
1992-01-28 |
Kullenberg Fred W |
Adjuvant for dose treatment with antigens
|
|
US4920016A
(en)
|
1986-12-24 |
1990-04-24 |
Linear Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US6093406A
(en)
|
1988-06-02 |
2000-07-25 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccine for induction of immunity to malaria
|
|
FR2649013B1
(fr)
|
1989-07-03 |
1991-10-25 |
Seppic Sa |
Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
|
|
US5015476A
(en)
|
1989-08-11 |
1991-05-14 |
Paravax, Inc. |
Immunization implant and method
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
IE904098A1
(en)
|
1989-11-13 |
1991-05-22 |
Nova Pharm Corp |
Lipospheres for controlled delivery of substances
|
|
US5091188A
(en)
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
|
JP3187419B2
(ja)
|
1990-05-29 |
2001-07-11 |
アメリカン・サイアナミド・カンパニー |
ブタ肺炎ワクチンおよびその製造方法
|
|
US5709879A
(en)
|
1990-06-29 |
1998-01-20 |
Chiron Corporation |
Vaccine compositions containing liposomes
|
|
ES2138588T3
(es)
|
1990-06-29 |
2000-01-16 |
Chiron Corp |
Composiciones de vacunas que contienen liposomas.
|
|
DE69131992T2
(de)
|
1990-12-12 |
2000-06-29 |
Csl Ltd., Parkville |
Papillomavirusuntereinheit-impfstoff
|
|
CA2072249C
(en)
|
1991-06-28 |
2003-06-17 |
Saiko Hosokawa |
Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
|
|
HUT70269A
(en)
|
1991-08-13 |
1995-09-28 |
Biotech Australia Pty Ltd |
Immunostimulating compositions and their use
|
|
US6037135A
(en)
|
1992-08-07 |
2000-03-14 |
Epimmune Inc. |
Methods for making HLA binding peptides and their uses
|
|
FI944052A7
(fi)
|
1992-03-03 |
1994-09-02 |
Daiichi Seiyaku Co |
Oraalinen rokote
|
|
US5855894A
(en)
|
1992-03-30 |
1999-01-05 |
Pfizer Inc. |
Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
|
|
USRE37224E1
(en)
|
1992-06-05 |
2001-06-12 |
Dalhousie University |
Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant
|
|
US5736141A
(en)
|
1992-06-05 |
1998-04-07 |
Dalhousie University |
Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant
|
|
CA2137363C
(en)
|
1992-06-05 |
1999-06-15 |
Robert Brown |
Use of zona pellucida glycoproteins for immunocontraception
|
|
SI9300468A
(en)
|
1992-10-14 |
1994-06-30 |
Hoffmann La Roche |
Injectable composition for the sustained release of biologically active compounds
|
|
US5820879A
(en)
|
1993-02-12 |
1998-10-13 |
Access Pharmaceuticals, Inc. |
Method of delivering a lipid-coated condensed-phase microparticle composition
|
|
JPH06247842A
(ja)
|
1993-02-23 |
1994-09-06 |
Green Cross Corp:The |
リポソーム組成物の製造方法
|
|
AU702517B2
(en)
|
1993-08-06 |
1999-02-25 |
Epimmune, Inc. |
Cloning and characterization of the complete MAGE-1 gene
|
|
BR9506885A
(pt)
|
1994-02-24 |
1997-08-19 |
Micro Pak Inc |
Vacinas contendo vesículas de lipidio paucilamelares como adjuvantes imunológicos
|
|
US5874560A
(en)
|
1994-04-22 |
1999-02-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Melanoma antigens and their use in diagnostic and therapeutic methods
|
|
WO1995031480A1
(en)
|
1994-05-18 |
1995-11-23 |
S.P.I. Synthetic Peptides Incorporated |
Heterodimer polypeptide immunogen carrier composition and method
|
|
US5688772A
(en)
|
1994-08-01 |
1997-11-18 |
University Of Saskatchewan |
Quinoa saponin compositions and methods of use
|
|
US5637300A
(en)
|
1994-08-03 |
1997-06-10 |
Dunbar; Bonnie S. |
Contraceptive vaccine comprising a glycosylated 55 kD zona pellucida protein immunogen and method of use of the same in contraception
|
|
FR2726764B1
(fr)
|
1994-11-14 |
1997-01-31 |
Pasteur Merieux Serums Vacc |
Adjuvant pour composition vaccinale
|
|
GB9422990D0
(en)
|
1994-11-15 |
1995-01-04 |
Cortecs Ltd |
Immunogenic compositions
|
|
FR2732895B1
(fr)
|
1995-04-11 |
1997-05-16 |
Pasteur Merieux Serums Vacc |
Utilisation d'un compose amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament
|
|
US6846489B1
(en)
|
1995-04-25 |
2005-01-25 |
Smithkline Beecham Biologicals S.A. |
Vaccines containing a saponin and a sterol
|
|
US5705151A
(en)
|
1995-05-18 |
1998-01-06 |
National Jewish Center For Immunology & Respiratory Medicine |
Gene therapy for T cell regulation
|
|
WO1996040066A1
(en)
|
1995-06-07 |
1996-12-19 |
The Governors Of The University Of Alberta |
A METHOD FOR ELICITING A Th1-SPECIFIC IMMUNE RESPONSE
|
|
US5840839A
(en)
|
1996-02-09 |
1998-11-24 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
|
|
US6096313A
(en)
|
1996-02-09 |
2000-08-01 |
Ludwig Institute For Cancer Research |
Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant
|
|
US7019112B1
(en)
|
1996-03-19 |
2006-03-28 |
University Of Virginia Patent Foundation |
Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytoxic lymphocytes, and uses therefor
|
|
CA2259469A1
(en)
|
1996-06-05 |
1997-12-11 |
Ashmont Holdings Limited |
Injectable compositions
|
|
US5919480A
(en)
|
1996-06-24 |
1999-07-06 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Liposomal influenza vaccine composition and method
|
|
AU3720097A
(en)
|
1996-07-12 |
1998-02-09 |
Baxter International Inc. |
A fibrin delivery device and method for forming fibrin on a surface
|
|
US6284267B1
(en)
|
1996-08-14 |
2001-09-04 |
Nutrimed Biotech |
Amphiphilic materials and liposome formulations thereof
|
|
US20060002949A1
(en)
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
|
US5910306A
(en)
|
1996-11-14 |
1999-06-08 |
The United States Of America As Represented By The Secretary Of The Army |
Transdermal delivery system for antigen
|
|
CA2203843C
(en)
|
1997-04-28 |
2013-07-23 |
Her Majesty The Queen, In Right Of Canada, As Represented By The Ministe R Of National Defence |
Liposome-encapsulated poly iclc
|
|
US6080725A
(en)
|
1997-05-20 |
2000-06-27 |
Galenica Pharmaceuticals, Inc. |
Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
|
|
AU8053898A
(en)
|
1997-05-28 |
1998-12-30 |
Jenner Biotherapies, Inc. |
Immunogenic compositions
|
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
AU8921698A
(en)
|
1997-08-29 |
1999-03-16 |
Human Genome Sciences, Inc. |
Follistatin-3
|
|
GB9718901D0
(en)
|
1997-09-05 |
1997-11-12 |
Smithkline Beecham Biolog |
Vaccine
|
|
US6291430B1
(en)
|
1997-09-12 |
2001-09-18 |
Ludwig Institute For Cancer Research |
Mage-3 peptides presented by HLA class II molecules
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
US6183746B1
(en)
|
1997-10-09 |
2001-02-06 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
|
AUPP060097A0
(en)
|
1997-11-28 |
1998-01-08 |
Commonwealth Scientific And Industrial Research Organisation |
Adjuvant system for enhanced response
|
|
JP4918188B2
(ja)
|
1997-12-16 |
2012-04-18 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
サブミクロンの水中油型エマルジョンと合わせた微粒子の使用
|
|
EP1067956B1
(en)
|
1998-04-03 |
2007-03-14 |
University Of Iowa Research Foundation |
Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
|
|
SE9801288D0
(sv)
|
1998-04-14 |
1998-04-14 |
Astra Ab |
Vaccine delivery system and metod of production
|
|
US6472375B1
(en)
|
1998-04-16 |
2002-10-29 |
John Wayne Cancer Institute |
DNA vaccine and methods for its use
|
|
US6632447B1
(en)
|
1998-05-07 |
2003-10-14 |
The University Of Tennessee Research Corporation |
Method for chemoprevention of prostate cancer
|
|
CN1306438A
(zh)
|
1998-05-07 |
2001-08-01 |
科里克萨有限公司 |
佐剂组合物及其使用方法
|
|
GB9810236D0
(en)
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
|
US6406719B1
(en)
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
|
AU768002B2
(en)
|
1998-06-15 |
2003-11-27 |
Oncoquest Inc. |
Immunotherapeutic composition and method for the treatment of prostate cancer
|
|
WO2000000178A1
(en)
|
1998-06-30 |
2000-01-06 |
Rohto Pharmaceutical Co., Ltd. |
Compositions containing liposomes and/or emulsions and process for the preparation thereof
|
|
FR2781160B1
(fr)
|
1998-07-03 |
2000-08-18 |
Pasteur Merieux Serums Vacc |
Utilisation d'un compose amphipathique pour adjuver un vaccin sous-unitaire
|
|
US6956021B1
(en)
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
|
US7087236B1
(en)
|
1998-09-01 |
2006-08-08 |
Merrion Research I Limited |
Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof
|
|
US20050084524A1
(en)
|
1998-09-30 |
2005-04-21 |
Alza Corporation |
Method for potentiating activity of a chemotherapeutic drug
|
|
US6787154B2
(en)
|
1998-10-20 |
2004-09-07 |
Salvatore Albani |
Artificial antigen presenting cells
|
|
CA2356452A1
(en)
|
1998-12-22 |
2000-06-29 |
Robert Brown |
Compositions and methods for reducing or preventing fertilization in fish and birds
|
|
US6790457B1
(en)
|
1998-12-22 |
2004-09-14 |
Dalhousie University |
Compositions and methods for reducing or preventing fertilization in fish and birds
|
|
AU769539B2
(en)
|
1999-01-29 |
2004-01-29 |
Zoetis Services Llc |
Adjuvants for use in vaccines
|
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
DK1187629T3
(da)
|
1999-04-19 |
2005-01-17 |
Glaxosmithkline Biolog Sa |
Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid
|
|
EP1178825B1
(en)
|
1999-05-13 |
2011-07-13 |
Wyeth Holdings Corporation |
Adjuvant combination formulations
|
|
WO2000071671A2
(en)
|
1999-05-26 |
2000-11-30 |
New York University |
New mutant genes in familial british dementia and familial danish dementia
|
|
EP1189597A4
(en)
|
1999-06-04 |
2008-06-18 |
Pacira Pharmaceuticals Inc |
COMPOSITIONS USING AN OIL CORE FOR DELAYED RELEASE HYDROPHOLE MEDICAMENTS
|
|
GB9923176D0
(en)
|
1999-09-30 |
1999-12-01 |
Smithkline Beecham Biolog |
Novel composition
|
|
ATE454901T1
(de)
|
1999-10-13 |
2010-01-15 |
Novartis Vaccines & Diagnostic |
Verfahren zur erhaltung zellimmuneantworten gegen proteinen
|
|
US6605696B1
(en)
|
1999-10-22 |
2003-08-12 |
Pfizer, Inc. |
Lawsonia intracellularis proteins, and related methods and materials
|
|
US6511676B1
(en)
|
1999-11-05 |
2003-01-28 |
Teni Boulikas |
Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
|
|
US7026443B1
(en)
|
1999-12-10 |
2006-04-11 |
Epimmune Inc. |
Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
|
|
US6602510B1
(en)
|
2000-04-05 |
2003-08-05 |
Epimmune Inc. |
HLA class I A2 tumor associated antigen peptides and vaccine compositions
|
|
CA2403553A1
(en)
|
2000-03-17 |
2001-09-27 |
David Johnson |
Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
|
|
US6228648B1
(en)
|
2000-03-17 |
2001-05-08 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of ADAM10 expression
|
|
JP2004505894A
(ja)
|
2000-06-02 |
2004-02-26 |
ユニバーシティー オブ コネティカット ヘルス センター |
免疫療法のためのα（２）マクログロブリンと抗原分子との複合体
|
|
JP4164361B2
(ja)
|
2000-11-07 |
2008-10-15 |
イムノワクチン テクノロジーズ インコーポレーテッド |
増強した免疫応答を有するワクチン、およびその調製方法
|
|
US20020160039A1
(en)
|
2000-12-01 |
2002-10-31 |
Biomira U.S.A., Inc. |
Preparation of large liposomes by infusion into peg
|
|
US7202034B2
(en)
|
2000-12-08 |
2007-04-10 |
Academisch Ziekenhuis Leiden |
Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
|
|
US20030045467A1
(en)
|
2001-01-05 |
2003-03-06 |
Tihamer Orban |
Autoantigen composition
|
|
US6497896B2
(en)
|
2001-02-12 |
2002-12-24 |
Supergen, Inc. |
Method for administering camptothecins via injection of a pharmaceutical composition comprising microdroplets containing a camptothecin
|
|
CN1168740C
(zh)
|
2001-04-04 |
2004-09-29 |
上海美恩生物技术有限公司 |
细胞因子基因修饰的抗原提呈细胞/肿瘤细胞偶联物、其制法和用途
|
|
US6676958B2
(en)
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
|
US20050037061A1
(en)
|
2001-07-25 |
2005-02-17 |
Saiko Hosokawa |
Remedies for mammary cancer
|
|
DE60238330D1
(de)
|
2001-07-31 |
2010-12-30 |
Univ Washington |
Immunologisch bedeutende herpes-simplex-virus-antigene und verfahren für ihre verwendung
|
|
US6517816B1
(en)
|
2001-12-26 |
2003-02-11 |
Avon Products, Inc. |
Sunscreen emulsion composition and method of use
|
|
AU2003244428A1
(en)
|
2002-02-08 |
2003-09-02 |
Immunovaccine Technologies Inc. |
Antigens for immunocontraception
|
|
US7056515B2
(en)
|
2002-02-08 |
2006-06-06 |
Immunovaccine Technologies Inc. |
Antigens for immunocontraception
|
|
US7569021B2
(en)
|
2002-03-21 |
2009-08-04 |
Jolife Ab |
Rigid support structure on two legs for CPR
|
|
AU2003277865B2
(en)
|
2002-06-25 |
2008-08-21 |
City Of Hope |
Adjuvant-free peptide vaccine
|
|
US20040213837A1
(en)
|
2002-08-05 |
2004-10-28 |
Sankaram Mantripragada |
Oil-core compositions for the sustained release of hydrophobic drugs
|
|
AU2003268087A1
(en)
|
2002-08-23 |
2004-03-11 |
Ian Ma |
Liposomal gemcitabine compositions for better drug delivery
|
|
EP1393720A1
(en)
|
2002-08-27 |
2004-03-03 |
Universiteit Utrecht |
Vesicle-encapsulated corticosteroids for treatment of cancer
|
|
DE10249401A1
(de)
|
2002-10-23 |
2004-05-13 |
Bernina Biosystems Gmbh |
Liposomen formende Zusammensetzung
|
|
US20050158375A1
(en)
|
2002-11-15 |
2005-07-21 |
Toshikiro Kimura |
Pharmaceutical composition containing liposomes for treating cancer
|
|
AU2003296330A1
(en)
|
2002-12-10 |
2004-06-30 |
Epimmune Inc. |
Hla-a1, a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions
|
|
KR101178816B1
(ko)
|
2002-12-23 |
2012-09-07 |
다이나박스 테크놀로지 코퍼레이션 |
면역자극성 서열 올리고뉴클레오타이드 및 이의 이용방법
|
|
US8034378B2
(en)
|
2002-12-27 |
2011-10-11 |
Novartis Vaccines And Diagnostics, Inc |
Immunogenic compositions containing phospholipid
|
|
DK1611153T3
(da)
|
2003-04-02 |
2010-10-18 |
Univ Texas |
Antitumoreffekt af mutant Bik
|
|
BRPI0408635B1
(pt)
|
2003-04-04 |
2019-07-16 |
Zoetis Services Llc |
Método de preparação de uma emulsão de óleo em água microfluidizada na faixa dos submicrômetros com um tamanho médio de gotícula de óleo inferior a 0,5 ?m, emulsão de óleo em água microfluidizada, método de preparação de uma composição de vacina microfluidizada e composições de vacina microfluidizadas
|
|
AU2004232971A1
(en)
|
2003-04-18 |
2004-11-04 |
Idm Pharma Inc. |
HLA-A2 tumor associated antigen peptides and compositions
|
|
WO2005000272A1
(en)
|
2003-06-04 |
2005-01-06 |
Isis Pharmaceuticals, Inc. |
Long-circulating liposomal compositions
|
|
US20050013812A1
(en)
|
2003-07-14 |
2005-01-20 |
Dow Steven W. |
Vaccines using pattern recognition receptor-ligand:lipid complexes
|
|
WO2005035714A2
(en)
|
2003-08-26 |
2005-04-21 |
Board Of Regents, The University Of Texas System |
Vaccines for cancer, autoimmune disease and infections
|
|
US20050220781A1
(en)
|
2003-09-04 |
2005-10-06 |
Duen-Hwa Yan |
IFIX, a novel HIN-200 protein, for cancer therapy
|
|
GB0321615D0
(en)
|
2003-09-15 |
2003-10-15 |
Glaxo Group Ltd |
Improvements in vaccination
|
|
GB0323965D0
(en)
|
2003-10-13 |
2003-11-19 |
Glaxosmithkline Biolog Sa |
Immunogenic compositions
|
|
US20050266066A1
(en)
|
2003-10-20 |
2005-12-01 |
Nof Corporation |
Phospholipid membrane preparation
|
|
WO2005039535A1
(en)
|
2003-10-24 |
2005-05-06 |
Alza Corporation |
Preparation of lipid particles
|
|
ATE434431T1
(de)
|
2003-11-14 |
2009-07-15 |
Het Nl Kanker I The Netherland |
Pharmazeutische formulierungen mit kurzketten- sphingolipiden und ihre verwendung
|
|
AU2005222776A1
(en)
|
2003-12-31 |
2005-09-29 |
Genimmune N.V. |
Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
|
|
JP2007522119A
(ja)
|
2004-01-28 |
2007-08-09 |
キュリックス エーピーエス |
アミロイド関連疾患用ワクチンとしてのアミロイドタンパク質のコンジュゲート
|
|
EP1737966B1
(en)
|
2004-04-02 |
2012-05-09 |
Board of Regents, The University of Texas System |
Cancer specific promoters
|
|
RU2347586C2
(ru)
|
2004-04-05 |
2009-02-27 |
Пфайзер Продактс Инк. |
Микрофлюидизированные эмульсии типа "масло в воде" и вакцинные композиции
|
|
GB0408164D0
(en)
|
2004-04-13 |
2004-05-19 |
Immune Targeting Systems Ltd |
Antigen delivery vectors and constructs
|
|
AU2005251691A1
(en)
|
2004-05-17 |
2005-12-22 |
Tekmira Pharmaceuticals Corporation |
Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
|
|
WO2006050155A2
(en)
|
2004-10-29 |
2006-05-11 |
Biomune, Inc. |
Cancer therapeutic compositions
|
|
US8337815B2
(en)
|
2004-12-23 |
2012-12-25 |
Discovery Laboratories, Inc. |
Pulmonary surfactant formulations
|
|
DK1850832T3
(en)
|
2005-02-07 |
2015-04-13 |
Lipotek Pty Ltd |
adjuvanting
|
|
CN101151280A
(zh)
*
|
2005-02-08 |
2008-03-26 |
昆士兰医学研究学院委员会 |
免疫原性分子
|
|
EP1874793A4
(en)
|
2005-04-15 |
2008-12-24 |
Univ Texas |
DISTRIBUTION OF SIRNA BY NEUTRAL LIPID COMPOSITIONS
|
|
US20060275777A1
(en)
|
2005-06-03 |
2006-12-07 |
Waelti Ernst R |
Novel strategies for protein vaccines
|
|
US8703095B2
(en)
|
2005-07-07 |
2014-04-22 |
Sanofi Pasteur S.A. |
Immuno-adjuvant emulsion
|
|
US20070059318A1
(en)
|
2005-08-15 |
2007-03-15 |
Balu-Iyer Sathy V |
Lipid nano particulates containing antigens as cancer vaccines
|
|
CA2523032A1
(en)
*
|
2005-10-07 |
2007-04-07 |
Immunovaccine Technologies Inc. |
Vaccines for cancer therapy
|
|
CA2632516C
(en)
|
2005-12-07 |
2018-05-15 |
Hemispherx Biopharma Inc. |
Dsrnas as influenza virus vaccine adjuvants or immuno-stimulants
|
|
TWI457133B
(zh)
*
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
US20090010959A1
(en)
|
2005-12-22 |
2009-01-08 |
Ralph Leon Biemans |
Pneumococcal Polysaccharide Conjugate Vaccine
|
|
CA2642994C
(en)
|
2006-02-24 |
2015-09-01 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Immunogenic page-4 peptides and methods of use
|
|
CA2643322C
(en)
|
2006-02-24 |
2015-07-21 |
Novartis Ag |
Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions
|
|
EP2441469A1
(en)
|
2006-03-14 |
2012-04-18 |
Oregon Health and Science University |
Methods for producing an immune response to tuberculosis
|
|
CA2660310C
(en)
|
2006-03-30 |
2015-04-21 |
The Research Foundation Of State University Of New York |
Compositions of less immunogenic and long-circulating protein-lipid complexes
|
|
US20080014217A1
(en)
|
2006-07-17 |
2008-01-17 |
Emmanuel Jules Hanon |
Influenza vaccine
|
|
US20090181078A1
(en)
*
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
US8877206B2
(en)
|
2007-03-22 |
2014-11-04 |
Pds Biotechnology Corporation |
Stimulation of an immune response by cationic lipids
|
|
US20090032666A1
(en)
|
2007-07-31 |
2009-02-05 |
Chun Fu Kuo |
Mouse pad
|
|
JP5731198B2
(ja)
|
2007-09-27 |
2015-06-10 |
イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． |
インビボでのポリヌクレオチドの送達のための連続疎水相を含む担体におけるリポソームの使用
|
|
US20100209452A1
(en)
*
|
2007-10-03 |
2010-08-19 |
Immunovaccine Technologies, Inc |
Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
|
|
JP5591705B2
(ja)
|
2007-10-03 |
2014-09-17 |
イムノバクシーン・テクノロジーズ・インコーポレイテッド |
抗原、両親媒性化合物及び疎水性担体を含有する組成物、並びにその使用
|
|
KR100900837B1
(ko)
*
|
2007-12-07 |
2009-06-04 |
(주)두비엘 |
리포펩타이드와 폴리(ｉ:ｃ)를 아쥬반트로 포함하는 강력한백신 조성물
|
|
WO2009146523A1
(en)
|
2008-06-05 |
2009-12-10 |
Immunovaccine Technologies Inc. |
Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
|
|
IN2014CN02581A
(cg-RX-API-DMAC7.html)
*
|
2011-10-06 |
2015-08-07 |
Immunovaccine Technologies Inc |
|